|
DynPort Vaccine Company LLC (DVC) manages product development programs for U.S. government agencies, and provides consulting, technical and program management services to companies in the biotechnology and pharmaceutical industries. The company’s portfolio includes vaccines and therapeutics to protect against emerging infectious diseases including biological and chemical warfare threat agents and seasonal and pandemic influenza. DVC is a wholly owned subsidiary of CSC (NYSE: CSC). For more information, visit www.csc.com/dvc.
^
|
|
Gold sponsor:
Silver sponsors:
  
Bronze sponsors:
  
Partner:
Documentation
Click here to review a comprehesive list of presentations given at Phacilitate's previous 19 Forums. All documentation is available to purchase.
|
|
